These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24094713)

  • 41. Head and Neck Paragangliomas: Overview of Institutional Experience.
    Vimawala SN; Graboyes AZ; Bennett B; Bonanni M; Abbasi A; Oliphant T; Alonso-Basanta M; Rassekh C; Cohen D; Brant JA; Huan Y
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imaging and management of head and neck paragangliomas.
    van den Berg R
    Eur Radiol; 2005 Jul; 15(7):1310-8. PubMed ID: 15809825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Head and Neck Paragangliomas-A Genetic Overview.
    Majewska A; Budny B; Ziemnicka K; Ruchała M; Wierzbicka M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring the link between tumour metabolism and succinate dehydrogenase deficiency: A
    Reichert T; Fakhry N; Lavieille JP; Amodru V; Sebag F; Romanet P; Loundou A; Castinetti F; Pacak K; Montava M; Taïeb D
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):879-884. PubMed ID: 31479526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
    Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
    Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. (68)Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to (123)I-MIBG SPECT/CT.
    Kroiss A; Shulkin BL; Uprimny C; Frech A; Gasser RW; Url C; Gautsch K; Madleitner R; Nilica B; Sprinzl GM; Gastl G; Fraedrich G; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):33-41. PubMed ID: 25134670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hereditary head and neck paraganglioma: from basics to practical consequences.
    Trache MC; Böttcher A; Betz CS
    Curr Opin Otolaryngol Head Neck Surg; 2023 Apr; 31(2):111-117. PubMed ID: 36912223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of octreotide therapy in progressive head and neck paragangliomas: case series.
    van Hulsteijn LT; van Duinen N; Verbist BM; Jansen JC; van der Klaauw AA; Smit JW; Corssmit EP
    Head Neck; 2013 Dec; 35(12):E391-6. PubMed ID: 23606330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
    Chang CA; Pattison DA; Tothill RW; Kong G; Akhurst TJ; Hicks RJ; Hofman MS
    Cancer Imaging; 2016 Aug; 16(1):22. PubMed ID: 27535829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The value of a rapid contrast-enhanced angio-MRI protocol in the detection of head and neck paragangliomas in SDHx mutations carriers: a retrospective study on behalf of the PGL.EVA investigators.
    Gravel G; Niccoli P; Rohmer V; Moulin G; Borson-Chazot F; Rousset P; Pasco-Papon A; Marcus C; Dubrulle F; Gouya H; Bidault F; Dupas B; Gabrillargues J; Caumont-Prim A; Hernigou A; Gimenez-Roqueplo AP; Halimi P
    Eur Radiol; 2016 Jun; 26(6):1696-704. PubMed ID: 26427697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative biomarkers allow the diagnosis of head and neck paraganglioma on multiparametric MRI.
    Arsovic E; Montava M; Fakhry N; Lavieille JP; Pacak K; Taïeb D; Varoquaux A
    Eur J Radiol; 2021 Oct; 143():109911. PubMed ID: 34508941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck.
    Duet M; Sauvaget E; Pételle B; Rizzo N; Guichard JP; Wassef M; Le Cloirec J; Herman P; Tran Ba Huy P
    J Nucl Med; 2003 Nov; 44(11):1767-74. PubMed ID: 14602858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypic variability and risk of malignancy in SDHC-linked paragangliomas: lessons from three unrelated cases with an identical germline mutation (p.Arg133*).
    Bickmann JK; Sollfrank S; Schad A; Musholt TJ; Springer E; Miederer M; Bartsch O; Papaspyrou K; Koutsimpelas D; Mann WJ; Weber MM; Lackner KJ; Rossmann H; Fottner C
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E489-96. PubMed ID: 24423348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
    Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
    J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Necessity for long-term follow-up of patients with head and neck paraganglioma and mutation in the succinate dehydrogenase genes: an index case report and literature review.
    Samji KB; Crown AL; Buxton-Thomas MS; Aylwin SJ; Schulte KM; Dizdarevic S
    Endocr Pract; 2012; 18(5):e130-4. PubMed ID: 22982783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diagnostic evaluation of temporal paragangliomas].
    Szymańska A; Gołabek W; Szymański M; Morshed K; Trojanowska A
    Otolaryngol Pol; 2007; 61(6):931-6. PubMed ID: 18546938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
    Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas.
    Al-Harthy M; Al-Harthy S; Al-Otieschan A; Velagapudi S; Alzahrani AS
    Endocr Pract; 2009 Apr; 15(3):194-202. PubMed ID: 19364686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
    Taïeb D; Tessonnier L; Sebag F; Niccoli-Sire P; Morange I; Colavolpe C; De Micco C; Barlier A; Palazzo FF; Henry JF; Mundler O
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):580-6. PubMed ID: 18394015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paragangliomas of the head and neck: diagnosis and treatment.
    Boedeker CC; Ridder GJ; Schipper J
    Fam Cancer; 2005; 4(1):55-9. PubMed ID: 15883711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.